Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.

Authors :: Sumnall HR
Jerome L
Doblin R
Mithoefer MC
Source :: Psychopharmacology [Psychopharmacology (Berl)] 2004 Jan; Vol. 171 (2), pp. 229-30. Date of Electronic Publication: 2003 Nov 21.
Publication Year :: 2004

Subjects :: Animals
Hallucinogens adverse effects
Humans
Illicit Drugs adverse effects
N-Methyl-3,4-methylenedioxyamphetamine adverse effects
Neurotoxicity Syndromes metabolism
Parkinson Disease, Secondary metabolism
Primates
Psychomotor Disorders metabolism
Species Specificity
Dopamine metabolism
Hallucinogens administration & dosage
N-Methyl-3,4-methylenedioxyamphetamine administration & dosage
Neurotoxicity Syndromes etiology
Parkinson Disease, Secondary chemically induced
Psychomotor Disorders chemically induced

Full Text Access

Tools